MMP9 and neoplasm: An aminobisphosphonate zoledronic acid (zoledronate) reduces mobilization of MDSCs through suppressing bone marrow progenitor-derived and tumor-derived MMP-9 [97, 98] although one study reports that zoledronic acid impairs tumor-associated macrophage proliferation but not MDSCs [99].